Doxazosin gastrointestinal therapeutic system: a clinical perspective.
Mann
Samuel J
SJ
Department of Medicine, Division of Nephrology and Hypertension, New York Presbyterian Hospital, Weill/Cornell Medical Center, New York, NY 10021, USA. sjmann@med.cornell.edu
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D017292:Doxazosin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D041981:Gastrointestinal Tract / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic
D000317:Adrenergic alpha-Antagonists; D000959:Antihypertensive Agents; D017292:Doxazosin